127 related articles for article (PubMed ID: 19965316)
1. [Autologous stem cell therapy with surgical myocardial revascularization].
Durdu S; Cubukçuoğlu Deniz G; Akar AR
Anadolu Kardiyol Derg; 2009 Dec; 9(6):465-6. PubMed ID: 19965316
[No Abstract] [Full Text] [Related]
2. [Autologous stem cell therapy with surgical myocardial revascularization - The Rostock University experience].
Yerebakan C; Uğurlucan M; Kaminski A; Westphal B; Liebold A; Steinhoff G
Anadolu Kardiyol Derg; 2009 Dec; 9(6):457-64. PubMed ID: 19965315
[TBL] [Abstract][Full Text] [Related]
3. Autologous transplantation of CD133+ BM-derived stem cells as a therapeutic option for dilatative cardiomyopathy.
Ghodsizad A; Ruhparwar A; Marktanner R; Borowski A; Mohammad Hasani MR; Poll L; Vshivkov I; Stoldt V; Voelkel T; Piechaczek C; Burchardt ER; Stockschlaeder M; Sucker C; Gams E; Klein HM
Cytotherapy; 2006; 8(3):308-10. PubMed ID: 16793739
[TBL] [Abstract][Full Text] [Related]
4. Pilot study to evaluate the safety and feasibility of intracoronary CD133(+) and CD133(-) CD34(+) cell therapy in patients with nonviable anterior myocardial infarction.
Manginas A; Goussetis E; Koutelou M; Karatasakis G; Peristeri I; Theodorakos A; Leontiadis E; Plessas N; Theodosaki M; Graphakos S; Cokkinos DV
Catheter Cardiovasc Interv; 2007 May; 69(6):773-81. PubMed ID: 17394248
[TBL] [Abstract][Full Text] [Related]
5. Impact of preoperative left ventricular function and time from infarction on the long-term benefits after intramyocardial CD133(+) bone marrow stem cell transplant.
Yerebakan C; Kaminski A; Westphal B; Donndorf P; Glass A; Liebold A; Stamm C; Steinhoff G
J Thorac Cardiovasc Surg; 2011 Dec; 142(6):1530-9.e3. PubMed ID: 21664627
[TBL] [Abstract][Full Text] [Related]
6. Transcoronary bone marrow-derived progenitor cells in a child with myocardial infarction: first pediatric experience.
Limsuwan A; Pienvichit P; Limpijankit T; Khowsathit P; Hongeng S; Pornkul R; Siripornpitak S; Boonbaichaiyapruk S
Clin Cardiol; 2010 Aug; 33(8):E7-12. PubMed ID: 20632394
[TBL] [Abstract][Full Text] [Related]
7. Addendum to 'Intraoperative CD133+ cell transplantation during coronary artery bypass grafting in ischemic cardiomyopathy'†.
Klein HM; Assmann A; Heke M
Multimed Man Cardiothorac Surg; 2014 Jul; 2014():. PubMed ID: 24994660
[No Abstract] [Full Text] [Related]
8. Intracoronary infusion of CD133+ endothelial progenitor cells improves heart function and quality of life in patients with chronic post-infarct heart insufficiency.
Flores-Ramírez R; Uribe-Longoria A; Rangel-Fuentes MM; Gutiérrez-Fajardo P; Salazar-Riojas R; Cervantes-García D; Treviño-Ortiz JH; Benavides-Chereti GJ; Espinosa-Oliveros LP; Limón-Rodríguez RH; Monreal-Puente R; González-Treviño JL; Rojas-Martínez A
Cardiovasc Revasc Med; 2010; 11(2):72-8. PubMed ID: 20347795
[TBL] [Abstract][Full Text] [Related]
9. Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies.
Stamm C; Kleine HD; Choi YH; Dunkelmann S; Lauffs JA; Lorenzen B; David A; Liebold A; Nienaber C; Zurakowski D; Freund M; Steinhoff G
J Thorac Cardiovasc Surg; 2007 Mar; 133(3):717-25. PubMed ID: 17320570
[TBL] [Abstract][Full Text] [Related]
10. Combined transepicardial and transseptal implantation of autologous CD 133+ bone marrow cells during bypass grafting improves cardiac function in patients with low ejection fraction.
Soetisna TW; Sukmawan R; Setianto B; Mansyur M; Murni TW; Listiyaningsih E; Santoso A
J Card Surg; 2020 Apr; 35(4):740-746. PubMed ID: 32048356
[TBL] [Abstract][Full Text] [Related]
11. Intramyocardial implantation of CD133+ stem cells improved cardiac function without bypass surgery.
Klein HM; Ghodsizad A; Marktanner R; Poll L; Voelkel T; Mohammad Hasani MR; Piechaczek C; Feifel N; Stockschlaeder M; Burchardt ER; Kar BJ; Gregoric I; Gams E
Heart Surg Forum; 2007; 10(1):E66-9. PubMed ID: 17162408
[TBL] [Abstract][Full Text] [Related]
12. Intracoronary infusion of selected autologous bone marrow stem cells improves longitudinal myocardial strain and strain rate in patients with old anterior myocardial infarction without recent revascularization.
Karatasakis G; Leontiadis E; Peristeri I; Manginas A; Goussetis E; Graphakos S; Papadakis E; Cokkinos DV
Eur J Echocardiogr; 2010 Jun; 11(5):440-5. PubMed ID: 20308191
[TBL] [Abstract][Full Text] [Related]
13. Intra-coronary bone marrow mononuclear cell transplantation in patients with ST-elevation myocardial infarction: a randomized controlled study.
Srimahachota S; Boonyaratavej S; Rerkpattanapipat P; Wangsupachart S; Tumkosit M; Bunworasate U; Nakorn TN; Intragumtornchai T; Kupatawintu P; Pongam S; Saengsiri AO; Pothisri M; Sukseri Y; Bunprasert T; Suithichaiyakul T
J Med Assoc Thai; 2011 Jun; 94(6):657-63. PubMed ID: 21696072
[TBL] [Abstract][Full Text] [Related]
14. A pilot trial of autologous bone marrow mononuclear cell transplantation through grafting artery: a sub-study focused on segmental left ventricular function recovery and scar reduction.
Lu M; Liu S; Zheng Z; Yin G; Song L; Chen H; Chen X; Chen Q; Jiang S; Tian L; He Z; Hu S; Zhao S
Int J Cardiol; 2013 Oct; 168(3):2221-7. PubMed ID: 23478196
[TBL] [Abstract][Full Text] [Related]
15. How to measure the effects of the intracoronary stem cell therapy?
Tendera M; Wojakowski W
Eur J Echocardiogr; 2010 Jun; 11(5):438-9. PubMed ID: 20308192
[TBL] [Abstract][Full Text] [Related]
16. Risk and benefit of CD133+ progenitors.
Ascione R; Madeddu P
Circ Res; 2009 Jul; 105(2):e2. PubMed ID: 19608984
[No Abstract] [Full Text] [Related]
17. Stem cells show mixed results in MI patients.
Kahn J
J Interv Cardiol; 2006 Aug; 19(4):297-301. PubMed ID: 16881973
[No Abstract] [Full Text] [Related]
18. Autologous bone marrow-derived stem cell therapy in combination with TMLR. A novel therapeutic option for endstage coronary heart disease: report on 2 cases.
Klein HM; Ghodsizad A; Borowski A; Saleh A; Draganov J; Poll L; Stoldt V; Feifel N; Piecharczek C; Burchardt ER; Stockschläder M; Gams E
Heart Surg Forum; 2004; 7(5):E416-9. PubMed ID: 15799915
[TBL] [Abstract][Full Text] [Related]
19. Intracoronary administration of autologous bone marrow-derived progenitor cells in a critically ill two-yr-old child with dilated cardiomyopathy.
Rupp S; Bauer J; Tonn T; Schächinger V; Dimmeler S; Zeiher AM; Schranz D
Pediatr Transplant; 2009 Aug; 13(5):620-3. PubMed ID: 19067928
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative isolation and processing of BM-derived stem cells.
Ghodsizad A; Klein HM; Borowski A; Stoldt V; Feifel N; Voelkel T; Piechaczek Ch; Burchardt E; Stockschläder M; Gams E
Cytotherapy; 2004; 6(5):523-6. PubMed ID: 15512919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
